contact us

Mail:
contact@kinnov-therapeutics.com

Address:
Kinnov-Therapeutics
3, allée du titane
45100 Orléans, FRANCE

Co-funded by the horizon 2020 programme of the European Union

About us

Kinnov Therapeutics is dedicated to the R&D of innovative therapies against addiction. Supported by experienced scientists in the drug discovery and development, we have identified the key receptors of addiction. KT-110, our first-in-class lead composition, has been tested in phase 2 clinical trial for alcohol addiction.

Contact Us

Kinnov-Therapeutics

3, allée du titane
45100 Orléans, France

View Larger Map

Pages

Addictions: a major Public Health threat
Alcohol addiction
Business strategy
Company
Contact us
Home
Partners / Investors
Preclinical trials
Product KT-110
R&D / Pipeline